| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 40 |
| 1 | BEVACIZUMAB | 38 |
| 2 | EVEROLIMUS | 37 |
| 3 | OCTREOTIDE ACETATE | 35 |
| 4 | CAPECITABINE | 34 |
| 5 | PACLITAXEL | 27 |
| 6 | DOCETAXEL | 23 |
| 7 | DOCETAXEL ANHYDROUS | 23 |
| 8 | LETROZOLE | 22 |
| 9 | METOCLOPRAMIDE HYDROCHLORIDE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PASSIFLORA INCARNATA, IGNATIA AMARA, VALERIANA OFFICINALIS | 1 | 0.0833 |
| 1 | DEMECLOCYCLINE | 1 | 0.0044 |
| 2 | NITROFURANTOIN (MACROCRYSTALS) | 1 | 0.0016 |
| 3 | ADEFOVIR DIPIVOXIL | 2 | 0.0016 |
| 4 | LANREOTIDE ACETATE | 12 | 0.0015 |
| 5 | CABAZITAXEL | 5 | 0.0014 |
| 6 | I. V. FAT EMULSION | 1 | 0.0014 |
| 7 | NERATINIB | 3 | 0.0013 |
| 8 | REGORAFENIB | 14 | 0.0012 |
| 9 | OCTREOTIDE ACETATE | 35 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 73 |
| 1 | Kinase Inhibitor [EPC] | 68 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 51 |
| 3 | Corticosteroid [EPC] | 42 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 39 |
| 5 | mTOR Inhibitor Immunosuppressant [EPC] | 38 |
| 6 | Microtubule Inhibitor [EPC] | 36 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 8 | Aromatase Inhibitor [EPC] | 30 |
| 9 | Benzodiazepine [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 15 | 0.0007 |
| 1 | Somatostatin Analog [EPC] | 4 | 0.0006 |
| 2 | Cannabinoid [EPC] | 4 | 0.0005 |
| 3 | Estrogen Receptor Antagonist [EPC] | 17 | 0.0004 |
| 4 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 5 | Calcitonin [EPC] | 1 | 0.0003 |
| 6 | Platinum-based Drug [EPC] | 73 | 0.0003 |
| 7 | Aromatase Inhibitor [EPC] | 30 | 0.0003 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 11 | 0.0002 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 5 | 0.0002 |